ImmunoGen, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
IMGN on Nasdaq
Industry
Pharmaceutical Preparations
Location
830 Winter St, Waltham, Massachusetts

Insiders trading volume in the past year

ImmunoGen, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Anna Berkenblit Svp & Chief Medical Officer $3.38 M Jun 30, 2023
Thomas Ryll SVP, Technical Operations $2.51 M Jun 30, 2021
Kristen Harrington-Smith Svp & Chief Commercial Officer $2.21 M Nov 15, 2022
Stacy Ann Coen Svp & Chief Business Officer $1.38 M -$4.86 M -77.8% Feb 12, 2024
Mark J. Enyedy CHIEF EXECUTIVE OFFICER, Director $898 K -$51.7 M -98.3% Feb 12, 2024
Susan ALTSCHULLER Svp And Cfo $564 K May 20, 2022
Renee Lentini Vp & Prin Acctg Officer $245 K -$6.23 M -96.2% Feb 12, 2024
Daniel Char Svp & Chief Legal Officer $0 Feb 12, 2024
Stephen C. Mccluski Director $0 Feb 12, 2024
Richard John Wallace Director $0 Feb 12, 2024
Isabel Kalofonos Svp & Chief Commercial Officer $0 Feb 12, 2024
Theresa Wingrove Svp Of Regulatory Affairs $0 -$22.9 M -100% Feb 12, 2024
Kristine Peterson Director $0 -$578 K -100% Feb 12, 2024
Dean J. Mitchell Director $0 Feb 12, 2024
Mark Alan Goldberg Director $0 Feb 12, 2024
Stuart A. Arbuckle Director $0 Feb 12, 2024
Helen M. Thackray Director $0 Feb 12, 2024
Tracey L. McCain Director $0 Feb 12, 2024
Lauren White Svp, Cfo And Pfo $0 Feb 12, 2024
Michael Vasconcelles Evp R&D & Medical Affairs $0 Feb 12, 2024

Recent Insider Transactions by Companies or Individuals for ImmunoGen, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership